Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Acquired by Bard Associates Inc.

Bard Associates Inc. boosted its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 349,526 shares of the company’s stock after acquiring an additional 4,474 shares during the quarter. Bard Associates Inc. owned 0.90% of Viemed Healthcare worth $2,803,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans raised its position in shares of Viemed Healthcare by 0.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock worth $25,110,000 after acquiring an additional 21,047 shares in the last quarter. Wasatch Advisors LP grew its position in shares of Viemed Healthcare by 19.6% in the 3rd quarter. Wasatch Advisors LP now owns 1,848,884 shares of the company’s stock valued at $13,552,000 after buying an additional 303,277 shares during the last quarter. Raffles Associates LP raised its stake in Viemed Healthcare by 11.0% during the 3rd quarter. Raffles Associates LP now owns 402,691 shares of the company’s stock worth $2,952,000 after acquiring an additional 40,000 shares in the last quarter. Rice Hall James & Associates LLC purchased a new stake in Viemed Healthcare in the fourth quarter valued at $2,083,000. Finally, Millrace Asset Group Inc. boosted its stake in Viemed Healthcare by 13.3% in the third quarter. Millrace Asset Group Inc. now owns 231,322 shares of the company’s stock valued at $1,696,000 after acquiring an additional 27,084 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Down 3.7 %

Viemed Healthcare stock opened at $7.55 on Tuesday. The stock has a 50-day simple moving average of $8.06 and a 200-day simple moving average of $8.18. The company has a market capitalization of $293.97 million, a P/E ratio of 27.96 and a beta of 1.45. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare, Inc. has a fifty-two week low of $6.21 and a fifty-two week high of $10.44.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.